Evidence map›Paper›PMID 39195253›Full record

ArticleCells2024

Role of Piezo1 in Terminal Density Reversal of Red Blood Cells.

Kuntal Dey, Ankie M van Cromvoirt, Inga Hegemann, Jeroen S Goede, Anna Bogdanova

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kuntal DeyRed Blood Cell Research Group, Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland.
Ankie M van CromvoirtRed Blood Cell Research Group, Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland.ORCID 0000-0003-0741-1948
Inga HegemannDepartment of Medical Oncology and Hematology, University Hospital and University of Zurich, CH-8091 Zurich, Switzerland.
Jeroen S GoedeDepartment of Hematology, Kantonsspital Winterthur, CH-8401 Winterthur, Switzerland.ORCID 0000-0001-7054-0174
Anna BogdanovaRed Blood Cell Research Group, Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland.ORCID 0000-0003-0502-5381

Funding

Swiss National Science Foundation 320030E_180227/1Swiss National Science Foundation CRSII5_180234
6 · The paper itself

Abstract

Density reversal of senescent red blood cells has been known for a long time, yet the identity of the candidate ion transporter(s) causing the senescent cells to swell is still elusive. While performing fractionation of RBCs from healthy individuals in Percoll density gradient and characterization of the separated fractions, we identified a subpopulation of cells in low-density fraction (1.02% ± 0.47) showing signs of senescence such as loss of membrane surface area associated with a reduction in band 3 protein abundance, and Phosphatidylserine (PS) exposure to the outer membrane. In addition, we found that these cells are overloaded with Na

Indexed as

CalciumErythrocytesIon ChannelsCellular SenescenceHumansPlasma Membrane Calcium-Transporting ATPasesSodiumCalciumIon ChannelsPIEZO1 protein, humanPlasma Membrane Calcium-Transporting ATPasesSodiumcalciumPiezo1red blood cellssenescenceterminal density reversal

Identifiers

PMID39195253
PMCPMC11352946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.